Director, Search & Evaluation Early TA Lead

Position Summary

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we’re building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.

We are looking for a Director, Search & Evaluation Early TA Lead to spearhead strategic sourcing and evaluation of external innovation opportunities across key therapeutic areas: Immunology, Hematology, and Cardiovascular/Renal. Embedded within each Therapeutic Area Leadership Team (TALT), this role will identify and advance high-potential assets from preclinical through Phase 1 clinical stages, shape early partnering strategies, and drive transactions in collaboration with Business Development.

Main Responsibilities & Accountabilities

• Lead proactive sourcing and scouting efforts for preclinical and Phase 1 assets, building a robust pipeline of opportunities aligned with Therapeutic Area (TA) strategy.
• Co-lead internal meetings (with Late Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL’s therapeutic areas. These NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations.
• Develop and execute early partnering strategies, including onboarding approaches and competitive positioning for priority assets.
• Drive cross-functional due diligence for each opportunity, coordinating scientific, clinical, regulatory, and commercial assessments to inform governance decisions.
• Partner closely with Business Development (BD) and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution.
• Represent the TA externally, leading sourcing activities at specialized conferences and cultivating relationships with biotech, academia, and investment communities.

Qualifications & Experience Requirements

• 12+ years in biopharma with significant experience in external innovation, search & evaluation, or business development.
• Advanced degree required (PhD, MD, or equivalent).
• Deep scientific expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas.
• Proven track record of leading due diligence and closing early-stage deals.
• Strong network within biotech, academia, and pharma Business Development organizations.

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

Key skills/competency

• External Innovation
• Search & Evaluation
• Business Development
• Due Diligence
• Therapeutic Area Expertise
• Strategic Sourcing
• Pipeline Management
• Negotiation
• Cross-functional Leadership
• Biopharma Industry Knowledge